Literature DB >> 21764590

N-substituted homopiperazine barbiturates as gelatinase inhibitors.

Jun Wang1, Carlos Medina, Marek W Radomski, John F Gilmer.   

Abstract

Matrix metalloproteinases are implicated in a wide range of pathophysiological processes and potent selective inhibitors for these enzymes continue to be eagerly sought. 5,5-Disubstituted barbiturates hold promise as inhibitor types being stable in vivo and relatively selective for the gelatinases (MMP-2 and MMP-9). In this paper we describe the synthesis of 5-piperazine and -homopiperazine substituted barbiturates. The activity of these compounds as gelatinase inhibitors was evaluated using supernatants from 12-O-tetradecanoylphorbol-13-acetate (PMA)-stimulated HT-1080 cells as well as using recombinant human MMPs. N-Acyl homopiperazine compounds were found to be potent inhibitors of the gelatinases (range in nM) and generally more potent than the corresponding piperazine analogues. The panel of N-acyl homopiperazines was enlarged in order to exploit differences between the gelatinases at the S2' site in order to design MMP-2- or MMP-9-selective inhibitors. Compounds in this group exhibited single digit nano-molar potency and some selectivity between the two enzymes. Representative potent compounds were effective inhibitors of cancer cell migration.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21764590     DOI: 10.1016/j.bmc.2011.06.055

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Detection of MMP-2 and MMP-9 activity in vivo with a triple-helical peptide optical probe.

Authors:  Walter J Akers; Baogang Xu; Hyeran Lee; Gail P Sudlow; Gregg B Fields; Samuel Achilefu; W Barry Edwards
Journal:  Bioconjug Chem       Date:  2012-02-29       Impact factor: 4.774

2.  Insights into the complex formed by matrix metalloproteinase-2 and alloxan inhibitors: molecular dynamics simulations and free energy calculations.

Authors:  Ilenia Giangreco; Gianluca Lattanzi; Orazio Nicolotti; Marco Catto; Antonio Laghezza; Francesco Leonetti; Angela Stefanachi; Angelo Carotti
Journal:  PLoS One       Date:  2011-10-05       Impact factor: 3.240

3.  Direct Synthesis of 5-Aryl Barbituric Acids by Rhodium(II)-Catalyzed Reactions of Arenes with Diazo Compounds.

Authors:  Daniel Best; David J Burns; Hon Wai Lam
Journal:  Angew Chem Int Ed Engl       Date:  2015-05-08       Impact factor: 15.336

4.  New methodology for the synthesis of thiobarbiturates mediated by manganese(III) acetate.

Authors:  Ahlem Bouhlel; Christophe Curti; Patrice Vanelle
Journal:  Molecules       Date:  2012-04-10       Impact factor: 4.411

5.  Cardioprotective effect of MMP-2-inhibitor-NO-donor hybrid against ischaemia/reperfusion injury.

Authors:  Anna Krzywonos-Zawadzka; Aleksandra Franczak; Agnieszka Olejnik; Marek Radomski; John F Gilmer; Grzegorz Sawicki; Mieczysław Woźniak; Iwona Bil-Lula
Journal:  J Cell Mol Med       Date:  2019-02-07       Impact factor: 5.310

6.  Palladium-Catalyzed α-Arylation of Cyclic β-Dicarbonyl Compounds for the Synthesis of CaV1.3 Inhibitors.

Authors:  Jisu Yun; Dayeon Jeong; Zhong Xie; Sol Lee; Jiho Kim; D James Surmeier; Richard B Silverman; Soosung Kang
Journal:  ACS Omega       Date:  2022-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.